Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

5.21
+0.10001.96%
Post-market: 5.230.0200+0.38%19:30 EDT
Volume:713.74K
Turnover:3.69M
Market Cap:163.02M
PE:-1.26
High:5.28
Open:5.06
Low:5.01
Close:5.11
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.32
T/O Rate:3.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.74
PE(LYR):-1.83

Loading ...

BioXcel Therapeutics Initiates Chapter 11 and Sale Process

TIPRANKS
·
Aug 28

Kazia Therapeutics Cuts ATM Offering Capacity to $80 Million

TIPRANKS
·
Aug 28

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

GlobeNewswire
·
Aug 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

PYC Therapeutics Details Governance and Operations in 2026 Annual Report

TIPRANKS
·
Aug 28

PYC Therapeutics Narrows Loss and Strengthens Balance Sheet in FY2026

TIPRANKS
·
Aug 28

Alterity Therapeutics Files Updated Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

Alterity Therapeutics Doubles Annual Loss as It Ramps Up Neurodegeneration R&D

TIPRANKS
·
Aug 28

Amplia Therapeutics Highlights Strong Pancreatic Cancer Data in AGM CEO Presentation

TIPRANKS
·
Aug 28

Kazia Therapeutics Posts 100% Clinical Benefit in Early Triple-Negative Breast Cancer Paxalisib Study

TIPRANKS
·
Aug 28

Quince Therapeutics Announces Planned Presidential Leadership Transition

TIPRANKS
·
Aug 28

Rein Therapeutics Receives Nasdaq Delisting Notice Over Bid Price

TIPRANKS
·
Aug 28

ADRs Close Higher; Kazia Therapeutics Ltd. Climbs 16%

Dow Jones
·
Aug 28

Kazia Therapeutics reports 100% clinical benefit rate in breast cancer treatment

TIPRANKS
·
Aug 28

Kazia Therapeutics announces offering of ADS, warrants

TIPRANKS
·
Aug 28

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

GlobeNewswire
·
Aug 28

Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

GlobeNewswire
·
Aug 27

Serina Therapeutics Establishes Flexible Equity Financing Agreement

TIPRANKS
·
Aug 27

JW Therapeutics Narrows Interim Loss as Carteyva Sales Jump and Costs Ease

TIPRANKS
·
Aug 27

The Consensus EPS Estimates For GenFleet Therapeutics (Shanghai) Inc. (HKG:2595) Just Fell Dramatically

Simply Wall St.
·
Aug 27